Business
Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program
Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program\n \n \nEaston Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program\n \n TORONTO, ON--(Marketwired - Apr 3, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces the appointment of Mr. Kent A. Deuters to the position of Chief Operations Officer and Special Advisor. \n Kent Deuters adds 20 years of financial banking, payment processing, branding, food industry and medical marijuana expertise. He has structured and developed business plans, patient acquisition strategies and operating procedures for several companies in the medical marijuana industry in both Canada and the United States. Mr. Deuters has an extensive well respected business background in both large and small international companies and highly experienced in business development. Easton Pharmaceuticals is aggressively looking to identify a diverse cross section of opportunities that will deliver shareholders accelerated growth and the substantial revenue streams. Kent Deuters is developing tactical business partnerships and joint ventures in the $900,000,000 per anum Colorado marijuana market and is seeking early entry into Washington, Oregon and other soon to be licensed states. Easton's pharmaceutical's industry experience will also allow them to develop alternate delivery systems for medicinal users on top of our Viorra and other brand of products through the assistance of BMV Medica in Mexico. \n Kent has been brought on board specifically in the short term, to quickly evaluate all medical marijuana proposals Easton Pharmaceuticals has maintained, which has grown and presently involves negotiations with 4 companies or groups in Canada and one in Colorado. These include negotiations with a well established grower in British Columbia that has recently forwarded a revised proposal to Easton for review, an Ontario company that has filed for a well detailed growers application in Ontario, which includes privately owned growing f...